L25. Medical treatment of subglottic stenosis in granulomatosis with polyangiitis (Wegener's)

MeSH terms

• Anti-Inflammatory Agents / adverse effects
• Anti-Inflammatory Agents / therapeutic use*
• Antibodies, Monoclonal, Murine-Derived / adverse effects
• Antibodies, Monoclonal, Murine-Derived / therapeutic use
• Cyclophosphamide / adverse effects
• Cyclophosphamide / therapeutic use
• Drug Therapy, Combination
• Glucocorticoids / adverse effects
• Glucocorticoids / therapeutic use
• Granulomatosis with Polyangiitis / diagnosis
• Granulomatosis with Polyangiitis / drug therapy*
• Humans
• Immunosuppressive Agents / adverse effects
• Immunosuppressive Agents / therapeutic use*
• Laryngostenosis / diagnosis
• Laryngostenosis / drug therapy*
• Long-Term Care
• Methotrexate / adverse effects
• Methotrexate / therapeutic use
• Mycophenolic Acid / adverse effects
• Mycophenolic Acid / analogs & derivatives
• Mycophenolic Acid / therapeutic use
• Rituximab
• Secondary Prevention